Mundipharma to lead in Improving Cancer Care in Asia

3월 16, 2016 - Less than a minute read
  • Mundipharma Cancer Care Summit 증상 조절이 되지 않는 중증 및 고도 중증의 하지불안증후군 환자에 있어서 2차 치료제로 유일하게 허가 승인
  • 타진®서방정으로 하지불안증후군 환자들의 증상 및 삶의 질 향상 기대

(Singapore – March 21, 2016) We value your interest in the field of Oncology Supportive Care and have put together a one-day educational program focusing on the advances and best practices in this area, particularly in the management of Cancer Pain, Chemotherapy-induced Nausea and Vomiting (CINV) and Oral Mucositis. Sessions include plenary lectures by leading experts in the field followed by concurrent workshops and expert panel meetings, based on areas of interest and expertise.

Mundipharma to lead in Improving Cancer Care in Asia

Tags: